Victory Pharma Inc., a specialty pharmaceutical company headquartered in San Diego, has agreed to pay $11,420,743 to resolve federal civil and criminal liability arising from its marketing of the pharmaceutical products Naprelan, Xodol, Fexmid and Dolgic.

The settlement resolves allegations that Victory engaged in a scheme to promote its drugs by paying kickbacks to doctors to induce them to write prescriptions for Victory’s products, including prescriptions for patients covered by Medicare and other federal health insurance programs.   The kickbacks included tickets to professional and collegiate sporting events; tickets to concerts and plays; spa outings; golf and ski outings; dinners at expensive restaurants; and numerous other out-of-office events.   Victory also encouraged its sales representatives to schedule paid “preceptorships,” which involved sales representatives “shadowing” doctors in their offices.   The settlement also resolves allegations that Victory improperly used these preceptorships to induce doctors to prescribe Victory’s products.

The settlement resolves a False Claims Act lawsuit filed by a former sales representative for Victory.   As a reward for exposing this fraud on U.S. taxpayers, the whistleblower will receive $1.7 million.

For more information on this case, click here: http://www.justice.gov/opa/pr/2012/December/12-civ-1547.html

This entry was posted in False Claims Act, Whistleblower. Bookmark the permalink.

Comments are closed.